Comparison
3 Methylglutaconic Aciduria C3696376 vs 3m Syndrome 3 C3280146
Clinical comparison between 3 Methylglutaconic Aciduria and 3M Syndrome 3 for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria C3696376
A metabolic disorder causing abnormal acid buildup affecting multiple body systems including the brain. Severity varies widely among affected individuals. Care focuses on symptom management and metabolic support.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
3 Methylglutaconic Aciduria C3696376
0-10
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria C3696376
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria C3696376
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria C3696376
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
3 Methylglutaconic Aciduria C3696376
metabolic
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria C3696376
metabolic
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-C3696376 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria C3696376 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Metabolic illness | May involve abnormal acid accumulation and neurologic features; pattern varies. | Not described as a primary organic aciduria. | High |
| Growth | Growth effects may occur but are not defining here. | Intrauterine growth restriction and postnatal short stature are characteristic. | High |
| Facial or skeletal appearance | No defining facial or skeletal pattern is established by the source. | Distinctive facial features and musculoskeletal findings may be present. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria C3696376 when
Neurologic or suspected metabolic illness
The source emphasizes acid buildup, brain involvement, and metabolic support.
Moderate
Abnormal organic-acid finding
This is a laboratory abnormality requiring correlation, not a diagnosis by itself.
High
Multisystem disease without a growth-syndrome phenotype
Metabolic evaluation is more relevant than a primary skeletal diagnosis.
Moderate
Choose 3m Syndrome 3 C3280146 when
Prenatal and postnatal growth restriction
This matches the supplied core phenotype of 3M syndrome type 3.
High
Short stature with distinctive facial features
Clinical genetics assessment is more appropriate than assuming aciduria.
Moderate
Chronic musculoskeletal growth disorder
Supportive growth monitoring fits the described condition.
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria C3696376 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show elevated 3-methylglutaconic acid; no cutoff is supplied. | Not expected to establish the diagnosis. | An abnormal result is a finding and needs laboratory and clinical correlation. |
| Genetic testing | May be used to investigate a metabolic subtype when clinically indicated. | May confirm the suspected genetic growth syndrome. | Gene choice and variant interpretation require a genetics clinician; none is established here. |
| Growth assessment and skeletal imaging | No specific imaging pattern is established by the source. | May document growth restriction and skeletal features. | Imaging supports phenotype assessment but does not alone confirm either condition. |
Prognosis comparison
3 Methylglutaconic Aciduria C3696376
- Outcome
- Potentially severe and highly variable; individual prognosis is not established here.
- Factors
- Neurologic involvement, metabolic stability, and confirmed subtype.
3m Syndrome 3 C3280146
- Outcome
- Chronic moderate growth disorder in the supplied classification; individual outcome varies.
- Factors
- Degree of growth restriction and associated medical or skeletal needs.
Time frame: Both are described as chronic; survival figures are not supplied.
Diagnostic confirmation, complications, and access to appropriate specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic involvement | Brain involvement is described, with widely variable severity. Cognitive outcome is not established by the supplied description. New neurologic symptoms warrant clinician assessment. |
| Growth impairment | Possible but not the defining feature in this source. Central, chronic feature beginning before birth. Other endocrine and nutritional causes still require clinical consideration. |
| Acute metabolic decompensation | Acid accumulation may cause acute illness; frequency is not specified. Not described as a metabolic-crisis disorder. Emergency management depends on the confirmed diagnosis. |
Patient education highlights
- HighDifferent conditions
Similar names do not mean the same disease; specialist confirmation is needed.
- HighTest versus diagnosis
An abnormal organic-acid result is not automatically a diagnosis.
- MediumCare focus
Care may emphasize metabolic support on the left and growth monitoring on the right; no doses are given here.